Open AccessRHAMNETIN IS A BETTER INHIBITOR OF SARS-COV-2 2’-O-METHYLTRANSFERASE THAN DOLUTEGRAVIR: A COMPUTATIONAL PREDICTION
Author(s) -
Adekunle Babajide Rowaiye,
Angus Nnamdi Oli,
Olukemi Onuh,
Nkoli W Emeter,
Doofan Bur,
Oluwaseun A. Obideyi,
Oluyomi Cornelius Dayisi,
Jude N. Akpa,
Lovelyn Birah,
Edward E. Omaka,
Frances Otibhor Iseghohi,
Akinbobola Peace Otitoju,
Philip F. Uzor,
Jude Nnaemeka Okoyeh
Publication year - 2022
Publication title -
african journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.386
H-Index - 11
eISSN - 2505-0419
pISSN - 2006-0165
DOI - 10.21010/ajid.v16i2.9
Subject(s) - dolutegravir , covid-19 , medicine , pharmacology , virology , human immunodeficiency virus (hiv) , viral load , antiretroviral therapy , disease , infectious disease (medical specialty)